CLINICAL_TRIALS
trial_result
· 2018-02-13
Clinical Trial Update: Safety Study of Adjuvant Vaccine to Treat Melanoma Patients [Phase 1, Phase 2]
Summary
Safety study update for an adjuvant vaccine in melanoma patients completed phases 1 and 2 with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nina Bhardwaj | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-02-13